跳至主要内容
临床试验/NCT00332644
NCT00332644已完成4 期

Pharmacotherapies: Efficacy, Mechanisms and Algorithms

University of Wisconsin, Madison2 个研究点 分布在 1 个国家目标入组 1,504 人开始时间: 2004年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
1,504
试验地点
2
主要终点
7-day Point Prevalence of Smoking, Biochemically (Exhaled CO) Confirmed

研究概览

简要总结

The proposed work will advance the understanding and effectiveness of tobacco dependence treatment and result in more smokers quitting successfully.

详细描述

This research study will last for three years. The first year involves a comparison of smoking cessation medications (bupropion, nicotine patch, and nicotine lozenge), including medications used in combination. The results of this study may allow researchers and clinicians to decide which medications are best for helping people to quit smoking as well as what treatments work best for different people. In addition, the first year of this study may help to clarify how these medications work.The purpose of the second and third years of this research study will be to get long-term results on the physical health, mental health, lifestyle factors, and the overall quality of life of people attempting to quit smoking. The results of this study may help researchers and clinicians better understand the health improvements that come from quitting or not quitting smoking.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Smoke at least 10 cigarettes per day for the previous 6 months - Expired CO > 9 ppm - Motivated to quit smoking - Able to read and write English - Willing to complete required study assessments

排除标准

  • Uncontrolled hypertension (systolic >180mm Hg or diastolic >110mm Hg) - History of bipolar disorder or psychosis - Myocardial infarction or other serious cardiac problem in the previous 4 weeks - History of diagnosed anorexia and/or bulimia - Diagnosis of Alcohol Dependence in the previous 6 months by participant self-report or drinking 6 or more drinks on six or more days a week - History of seizure and/or serious head injury involving loss of consciousness - Use of contraindicated medications (MAO inhibitors, bupropion, lithium, anticonvulsants, antipsychotics) - Currently pregnant or breast-feeding - Unwilling to use effective contraception during the treatment phase - More than one participant from the same household - Allergic reactions to 3 or more classes of drugs

研究组 & 干预措施

1

Experimental

nicotine patch alone treatment

干预措施: nicotine patch (Drug)

2

Experimental

nicotine lozenge alone treatment

干预措施: nicotine lozenge (Drug)

3

Experimental

nicotine patch + lozenge combination treatment

干预措施: nicotine patch + nicotine lozenge (Drug)

4

Experimental

bupropion alone treatment

干预措施: bupropion (Drug)

5

Experimental

bupropion + nicotine lozenge combination treatment

干预措施: bupropion + lozenge (Drug)

6

Placebo Comparator

placebo control (no active medication) treatment

干预措施: placebo (Drug)

结局指标

主要结局

7-day Point Prevalence of Smoking, Biochemically (Exhaled CO) Confirmed

时间窗: 6 months post quit date

Smoking status was assessed both as 7-day point-prevalence abstinence ("Have you smoked at all, even a puff, in the last 7 days?") and continuous abstinence (smoking at all since the target quit day), using a smoking calendar and the timeline follow-back method. All participants' self-reports of smoking status during study visits were confirmed by an expired carbon monoxide level of less than 10 ppm measured using a Micro-3 Smokerlyzer (Bedfont Scientific, Williamsburg, Virginia).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验